Sintx Technologies, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Sintx Technologies, Inc. has filed its Q1 2024 10-Q report, detailing financial data and corporate history.</b>

AI Summary

Sintx Technologies, Inc. (SINT) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Sintx Technologies, Inc. filed a 10-Q for the period ending March 31, 2024. The filing covers the first quarter of fiscal year 2024. The company was formerly known as AMEDICA Corp. The filing includes data related to common stock, preferred stock, and additional paid-in capital. Key dates mentioned include February 10, 2023, related to common stock warrants and distribution agreements.

Why It Matters

For investors and stakeholders tracking Sintx Technologies, Inc., this filing contains several important signals. This 10-Q filing provides the latest financial snapshot of Sintx Technologies, Inc. for the first quarter of 2024, crucial for investors assessing the company's performance and financial health. The inclusion of historical data and former company names (AMEDICA Corp.) offers context for understanding the company's evolution and financial trajectory over time.

Risk Assessment

Risk Level: low — Sintx Technologies, Inc. shows low risk based on this filing. The filing is a standard 10-Q report, which typically contains routine financial disclosures and does not indicate any immediate or significant new risks.

Analyst Insight

Review the detailed financial statements and segment data within the 10-Q to understand revenue streams and operational performance for Q1 2024.

Key Numbers

• 2024-03-31 — Report Period End Date (10-Q filing)
• 2024-05-13 — Filing Date (10-Q filing)
• 2023-02-10 — Date (Related to common stock warrants and distribution agreements)

Key Players & Entities

• Sintx Technologies, Inc. (company) — Filer
• AMEDICA Corp (company) — Former company name
• Maxim Group LLC (company) — Mentioned in relation to distribution agreements

FAQ

Industry Context

Sintx Technologies operates in the medical devices sector, specifically focusing on surgical and medical instruments and apparatus.

Regulatory Implications

The filing is a standard 10-Q, a quarterly report required by the SEC for public companies to provide updates on their financial condition.

What Investors Should Do

1. Analyze the balance sheet and income statement for Q1 2024.
2. Review any disclosures related to debt, equity, and cash flow.
3. Check for updates on any ongoing legal or regulatory matters mentioned in previous filings.

Key Dates

• 2024-03-31: Quarterly Period End — End of the reporting period for the 10-Q filing.
• 2024-05-13: Filing Date — Date the 10-Q was officially filed with the SEC.
• 2023-02-10: Distribution Agreement / Warrant Event — Significant date related to equity transactions.

Year-Over-Year Comparison

This is the first 10-Q filing for the period ending March 31, 2024, following the 10-K filing for the fiscal year ending December 31, 2023.

Key Financial Figures

• $0.01 — 122,698,454 shares of common stock, $0.01 par value, were outstanding at May 8 ,
• $1.0 million — ibution Agreement for gross proceeds of $1.0 million. The Company is subject to General Inst

Filing Documents

• form10-q.htm (10-Q) — 726KB
• ex31-1.htm (EX-31.1) — 11KB
• ex31-2.htm (EX-31.2) — 11KB
• ex32.htm (EX-32) — 7KB
• 0001493152-24-018961.txt (&nbsp;) — 4243KB
• sint-20240331.xsd (EX-101.SCH) — 35KB
• sint-20240331_cal.xml (EX-101.CAL) — 51KB
• sint-20240331_def.xml (EX-101.DEF) — 154KB
• sint-20240331_lab.xml (EX-101.LAB) — 306KB
• sint-20240331_pre.xml (EX-101.PRE) — 240KB
• form10-q_htm.xml (XML) — 545KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 17

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 24

Controls and Procedures

Item 4. Controls and Procedures 24

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 25

Risk Factors

Item 1A. Risk Factors 25

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 25

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 25

Other Information

Item 5. Other Information 25

Exhibits

Item 6. Exhibits 26

Signatures

Signatures 27 2 SINTX Technologies, Inc. Condensed Consolidated Balance Sheets - Unaudited (in thousands, except share and per share data) March 31, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 5,762 $ 3,340 Account and other receivables, net of allowance totaling 109 and 72 respectively 483 685 Prepaid expenses and other current assets 366 539 Inventories 707 888 Other current assets 196 80 Total current assets 7,514 5,532 Inventories, net 469 333 Property and equipment, net 5,064 4,826 Intangible assets, net 20 21 Operating lease right of use asset 3,936 4,094 Other long-term assets 558 559 Total assets $ 17,561 $ 15,365 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 448 $ 636 Accrued liabilities 2,041 1,404 Current portion of long-term debt 233 46 Derivative liabilities 845 304 Current portion of operating lease liability 518 512 Other current liabilities 3 4 Total current liabilities 4,088 2,906 Operating lease liability, net of current portion 3,547 3,687 Total liabilities 7,635 6,593 Commitments and contingencies - - Stockholders' equity: Convertible preferred stock Series B, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 26 shares issued and outstanding as of March 31, 2024 and December 31, 2023. - - Convertible preferred stock Series C, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 50 shares issued and outstanding as of March 31, 2024 and December 31, 2023. - - Convertible preferred stock Series D, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 180 shares issued and outstanding as of March 31, 2024 and December 31, 2023. - - Preferred stock value - - Common stock, $ 0.01 par value, 250,000,000 shares authorized; 51,080,138 and 5,320,671 shar

View Full Filing

View this 10-Q filing on SEC EDGAR